Filing Details

Accession Number:
0001562180-19-003124
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-28 16:04:52
Reporting Period:
2019-05-23
Accepted Time:
2019-05-28 16:04:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100412 Array Biopharma Inc ARRY Pharmaceutical Preparations (2834) 841460811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1620368 Victor Sandor C/o Array Biopharma Inc.
3200 Walnut Street
Boulder CO 80301
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-23 40,634 $3.65 278,326 No 4 M Direct
Common Stock Disposition 2019-05-23 40,634 $26.50 237,692 No 4 S Direct
Common Stock Acquisiton 2019-05-28 46,766 $3.65 284,458 No 4 M Direct
Common Stock Disposition 2019-05-28 74,915 $27.00 209,543 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-05-23 40,634 $0.00 40,634 $3.65
Common Stock Stock Options (Right to buy) Disposition 2019-05-28 46,766 $0.00 46,766 $3.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
98,628 2024-09-22 No 4 M Direct
51,862 2024-09-22 No 4 M Direct
Footnotes
  1. These trades were made pursuant to a Rule 10b5-1 trading plan.
  2. The price reported for these shares is the weighted average sale price of transactions made at prices from $26.50 to $26.51. Details of actual prices for shares sold are available from the Issuer upon request.
  3. The price reported for these shares is the weighted average sale price of transactions made at prices from $26.75 to $27.10. Details of actual prices for shares sold are available from the Issuer upon request.
  4. The option vested in four equal annual installments beginning on September 22, 2015.